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Background: Staphylococcus aureus (S. aureus) is one of the primary causes of bone infections which are often
chronic and difficult to eradicate. Bacteria like S. aureus may survive upon internalization in cells and may be
responsible for chronic and recurrent infections. In this study, we compared the responses of a phagocytic cell
(i.e. macrophage) to a non-phagocytic cell (i.e. osteoblast) upon S. aureus internalization.
Results: We found that upon internalization, S. aureus could survive for up to 5 and 7 days within macrophages
and osteoblasts, respectively. Significantly more S. aureus was internalized in macrophages compared to osteoblasts
and a significantly higher (100 fold) level of live intracellular S. aureus was detected in macrophages compared to
osteoblasts. However, the percentage of S. aureus survival after infection was significantly lower in macrophages
compared to osteoblasts at post-infection days 1–6. Interestingly, macrophages had relatively lower viability in
shorter infection time periods (i.e. 0.5-4 h; significant at 2 h) but higher viability in longer infection time periods
(i.e. 6–8 h; significant at 8 h) compared to osteoblasts. In addition, S. aureus infection led to significant changes in
reactive oxygen species production in both macrophages and osteoblasts. Moreover, infected osteoblasts had
significantly lower alkaline phosphatase activity at post-infection day 7 and infected macrophages had higher
phagocytosis activity compared to non-infected cells.
Conclusions: S. aureus was found to internalize and survive within osteoblasts and macrophages and led to
differential responses between osteoblasts and macrophages. These findings may assist in evaluation of the
pathogenesis of chronic and recurrent infections which may be related to the intracellular persistence of bacteria
within host cells.
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Staphylococcus aureus (S. aureus) is one of the primary
causes of bone infections [1-3]. These infections are often
chronic, difficult to eradicate, and have high morbidity
rates [4]. S. aureus can infiltrate deep into bone and soft
tissue as a result of severe trauma or surgical implants [5].
Although S. aureus has traditionally been considered an
extracellular pathogen, it has been reported by several
groups that this bacterium can invade and survive within* Correspondence: bili@hsc.wvu.edu
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unless otherwise stated.a variety of cells such as neutrophils, macrophages,
T-lymphocytes, epithelial cells, endothelial cells, fibro-
blasts, and osteoblasts [6-16]. One hypothesis, not yet
proven, about chronic and recurrent infections is that
bacteria internalize into host cells and the internalization
may lead to the bacteria’s evasion of the host’s immune re-
sponses and provide protection from most conventional
antibiotics [17,18].
The primary role of osteoblasts is to synthesize bone
components and induce bone matrix mineralization
[19]. Osteoblasts are not traditionally considered part of
the immune system. However, osteoblasts were recently
found to be able to induce inflammatory cytokines and
chemokines upon S. aureus internalization [20,21]. This
finding may suggest an important role for osteoblasts inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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aureus can be internalized into osteoblasts and its internal-
ization is believed to be mediated by binding of fibronectin-
binding proteins on S. aureus surfaces and fibronectins on
osteoblast surfaces, which are connected to the integrin
dimer α5β1 molecule [6]. Protein-ligand interaction leads
to S. aureus adhesion and invasion by a “zipper-like” mech-
anism [15]. Eventually, internalized bacteria escape into
the cytoplasm and may lead to host cell death by apop-
tosis [22]. In addition, live osteoblasts are necessary for
S. aureus internalization as S. aureus could not internalize
into formalin-fixed osteoblasts [10,23].
The major role of phagocytes like macrophages, neutro-
phils, and dendritic cells is to engulf and eliminate a wide
variety of invading pathogens. As a result, high influxes of
such phagocytes are expected at the infection site upon
pathogen invasion. For instance, a high influx of neutro-
phils was detected at the infection site of S. aureus bone
infection [24]. Unfortunately, some pathogens can survive
within these phagocytes after being phagocytized which
may lead to chronic diseases [25,26]. It was reported that
S. aureus can survive within neutrophils and its survival
may have contributed to infection persistence as well as
dissemination in vivo [7]. Neutrophils are short-lived and
are unlikely to carry intracellular pathogens for long [27].
Macrophages, however, are long-lived and may possibly
allow surviving pathogens to invade the circulatory system
from localized infection sites [28] and thereby may be more
likely to contribute to chronic and recurrent infections.
The aims of this study were to compare S. aureus internal-
ization in a phagocytic cell (i.e. macrophage) to a non-
phagocytic cell (i.e. osteoblast) and to investigate macro-
phage and osteoblast responses upon S. aureus infection.
We hypothesized that S. aureus can internalize into macro-
phages and osteoblasts and lead to differential responses.
Results
Characterization of S. aureus infection of osteoblasts and
macrophages
S. aureus was incubated with osteoblasts or macrophages
for 2 h, with a multiplicity of infection (MOI) from 100:1
to 1000:1; the MOI represents the S. aureus to osteoblast
or macrophage ratio. Osteoblasts and macrophages were
both found to be infected. However, significantly higher
(~100 fold) numbers of intracellular S. aureus were found
within macrophages compared to osteoblasts (Figure 1A);
the intracellular colony forming units (CFUs) for infected
macrophages and osteoblasts were approximately 3.5 ×
106 and 3.1 × 104 CFU/(105 cells), respectively. No signifi-
cant differences were observed in the same cell type at
the various MOIs studied (i.e. 100:1, 500:1, and 1000:1).
By contrast, significantly lower viability was observed in
macrophages compared to osteoblasts at 2 h infection;
the viability of macrophages and osteoblasts were 62-78%and 90-95%, respectively (Figure 1B). No significant differ-
ences in viability for the same cell type at the MOIs inves-
tigated (i.e. 100:1, 500:1, and 1000:1) were noted following
the 2 h infection.
At an MOI of 500:1, the number of intracellular S. aur-
eus for both macrophages and osteoblasts increased with
increasing infection time and reached a plateau at 2 h, at
which point the intracellular CFUs for macrophages and
osteoblasts were 5.0 × 106 and 3.9 × 104 CFU/(105 cells),
respectively (Figure 1C). At infection times of 2–8 h, the
intracellular CFUs for macrophages were significantly
higher (about 100 fold) than those of osteoblasts. At an
MOI of 500:1, the viability of macrophages and osteoblasts
decreased approximately linearly with increasing infection
time. The viability of macrophages at infection times of 2,
4, 6, and 8 h was significantly lower than that of both
macrophage control and at infection time of 0.5 h. The
viability of osteoblasts at infection times of 4, 6, and 8 h
was significantly lower than that of both osteoblast control
and at infection time of 0.5 h (Figure 1D). In addition, the
viability of macrophages was significantly lower at 2 h in-
fection but significantly higher at 8 h infection compared
to osteoblasts at corresponding infection time periods
(Figure 1D).
The S. aureus infection of osteoblasts was also found
to be significantly inhibited by the addition of cytochalasin
D. The intracellular CFUs of S. aureus decreased signifi-
cantly with increasing cytochalasin D at the dose range
studied (0.5-20 μg/mL), reaching 50% inhibition at 20 μg/mL
(Figure 1E). Relatively higher cytochalasin D doses of 10 and
20 μg/mL also led to significantly lower intracellular CFUs of
S. aureus compared to the doses of 0.5, 1, and 5 μg/mL
(Figure 1E).
S. aureus was found to be able to survive within mac-
rophages and osteoblasts for approximately a week; live
intracellular S. aureus was found in macrophages and
osteoblasts for 5 and 7 days, respectively (Figure 2). The
percentage of live intracellular S. aureus for both macro-
phages and osteoblasts decreased continuously with in-
creasing culturing time after infection, and significantly
reduced survival of S. aureus was found in macrophages
compared to osteoblasts at the same post-infection time
period (Figure 2). In addition, no differences in osteo-
blast proliferation were observed between infected and
non-infected osteoblasts within one week post-infection
(data not shown).
Confocal microscopy and transmission electron micros-
copy (TEM) images confirmed that S. aureus was internal-
ized and could survive within macrophages and osteoblasts
(Figure 3). Meanwhile, substantially more (likely 100 fold)
S. aureus was internalized (not necessarily alive) by macro-
phages compared to osteoblasts (Figures 3A and B). Con-
focal microscopy imaging also found that all live S. aureus
was inside the osteoblasts and there was no live S. aureus
Figure 1 S. aureus infection of osteoblasts and macrophages. (A) Live intracellular S. aureus and (B) viability of osteoblasts and macrophages
at different MOIs (100:1, 500:1, and 1000:1) for 2 h. *p < 0.05 and **p < 0.001 compared to osteoblasts at the same MOI. (C) Live intracellular S.
aureus and (D) viability of osteoblasts and macrophages at an MOI of 500:1 for various infection times. **p < 0.001 compared to osteoblasts at the
same infection time, &p < 0.01 compared to macrophages at infection times 0 and 0.5 h, ^p < 0.01 compared to osteoblasts at the same infection
times, and #p < 0.05 compared to osteoblasts at infection times 0 and 0.5 h. (E) Effect of cytochalasin D on S. aureus internalization in osteoblasts.
**p < 0.001 compared to the controls and ^^p < 0.001 compared to 0.5, 1, and 5 μg/mL.
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(Figure 3C); this finding was consistent with the bacterial
culturing of the washing media after gentamicin treat-
ments – no colonies were found from the washing media.
The internalization of S. aureus within osteoblasts was
found to be non-uniform as some osteoblasts had multiple
S. aureus bacteria while others had none (Figure 3D).
Biological responses of osteoblasts and macrophages
upon S. aureus infection
Significantly higher hydrogen peroxide (H2O2) levels were
observed at 0.5 and 1 h in infected osteoblasts comparedto non-infected osteoblasts, i.e. control (Figure 4A).
Significantly higher H2O2 levels were also observed fol-
lowing a 1 h infection in macrophages compared to the
non-infected control (Figure 4A). No significant changes
in superoxide anion (O.2
−) production in osteoblasts were
observed at the infection time periods studied (i.e. 0.5, 1,
and 2 h), while significantly higher O.2
− levels were found
in macrophages at 0.5 and 1 h infection (Figure 4B).
Significantly lower alkaline phosphatase (ALP) enzyme
activity was observed at post-infection day 7 in the infected
osteoblasts compared to the non-infected cells (i.e. control);
no significant changes in ALP enzyme activity were found
Figure 2 Survival of intracellular S. aureus within osteoblasts
and macrophages after infection at an MOI of 500:1 for 2 h.
**p < 0.001 compared to osteoblasts at the same post-infection time.
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and 4 (Figure 4C). The macrophage phagocytosis activity
studies showed that the ability to ingest bacteria was much
higher for infected macrophages (83%) compared to non-
infected ones (44%) (Figure 4D).
Discussion
S. aureus has been traditionally considered as an extracel-
lular pathogen; however, it has been shown to invade and
survive within both non-phagocytic and phagocytic cells.
By nature, the internalization and survival of S. aureus
within non-phagocytic and phagocytic cells would be ex-
pected to be different, and may play significantly different
roles in related diseases. The main goal of the present
study was to compare the internalization behavior and re-
lated biological responses of S. aureus in a non-phagocytic
cell (i.e. osteoblast) and a phagocytic cell (i.e. macro-
phage); our findings may contribute to the understand-
ing of the pathogenesis of many chronic and recurrent
infections.
In this study, S. aureus was internalized by both osteo-
blasts and macrophages. The infection of osteoblasts and
macrophages was observed as early as 0.5 h at an MOI of
500:1. With increasing infection time, the intracellular
CFUs of both osteoblasts and macrophages increased
significantly from 0.5 h to 2 h followed by a plateau
from 2 h to 8. Our data indicated that an intracellular
load of approximately one S. aureus per osteoblast
(Figure 1C) was sufficient to induce the death of ap-
proximately 10% of the osteoblast population within
2 h and 70% within 8 h (Figure 1D). Since macrophages
are supposed to engulf and eliminate pathogens on con-
tact, it was not surprising to find that, at the same infec-
tion conditions (i.e. MOI of 500:1 for 2 h), significantly
more (approximately 100 fold) S. aureus (live and dead)
was phagocytized by macrophages compared to thoseinternalized by osteoblasts. Similarly, significantly more
live intracellular S. aureus was seen in macrophages com-
pared to osteoblasts during infection times of 2–8 h. Mac-
rophages had significantly lower viability at a shorter
infection time period (i.e. 2 h) and significantly higher
survival at a longer infection time (i.e. 8 h) compared to
infected osteoblasts. In addition, it is possible that the
accumulation of toxins produced by S. aureus [29,30]
and the significantly higher levels of H2O2 in infected
osteoblasts and macrophages and O.2
− in infected macro-
phages affected the viability of macrophages and osteo-
blasts; both decreased (almost linearly) with increasing
infection time. Rasigade et al. reported that phenol-soluble
modulins, a class of membrane-damaging exoproteins,
acted as intracellular toxins and were involved in killing of
the host cells like osteoblasts, and they found that the
intracellular expression of psmα gene resulted in extensive
cell damage [31]. It seems that actin cytoskeleton forma-
tion played a major role in S. aureus internalization since
cytochalasin D, an inhibitor that disrupts actin filament
polymerization, led to up to 50% inhibition of S. aureus in-
ternalization. This finding was consistent with other stud-
ies [23,32] where actin filament was determined to play a
dominant role in S. aureus internalization. One limitation
of this study was that MOIs lower than 100:1 were not in-
vestigated and the higher MOI may only apply to infected
tissues where numerous bacteria may exist. Future studies
may need to consider lower MOIs.
Note that our data confirmed that gentamicin treatment
was effective in eliminating extracellular S. aureus and the
post-infection CFU was indeed from live intracellular S.
aureus. Gentamicin treatment is commonly used to elim-
inate extracellular bacteria [21,32], but such a procedure
lacks direct confirmation of live intracellular bacteria. In
this study, besides culturing the washing media collected
after gentamicin treatment, the dual staining approach
combined with confocal microscopy presented direct evi-
dence that no live extracellular S. aureus was observed
after the gentamicin treatment (Figure 3C).
S. aureus has been thought to be a frequent cause for
several types of chronic and recurrent infections including
osteomyelitis, endovascular diseases, and chronic lung in-
fections [33], and S. aureus infections have been reported
in clinical cases to persist asymptomatically with relapses
occurring months or even years after apparent antimicro-
bial cure of the infections [34,35]. In these cases, S. aureus
may have protected itself and escaped antibiotics and im-
mune response of the host by “hiding” intracellularly and
establishing a latent bacterial reservoir. This was sup-
ported by our observation that S. aureus could survive
intracellularly for up to 5 and 7 days, respectively, within
macrophages and osteoblasts (Figure 2). As a phagocytic
cell, macrophages were obviously more effective than os-





Figure 3 Visualization of intracellular S. aureus within (A) macrophages and (B-D) osteoblasts. Osteoblasts and macrophages were
infected with S. aureus at an MOI of 500:1 for 2 h. (A and B) S. aureus was stained with FITC before infection. Infected osteoblasts and
macrophages were fixed, blocked, stained first with primary antibody to S. aureus surface protein A, and then secondary antibody conjugated to
Cy-5. The nuclei of the macrophages were additionally stained with DAPI. Visualized at (I) 488 nm, (II) 633 nm, and (III) 405 nm. (IV) Merged images
of (I), (II), and (III). As a result, intracellular S. aureus is shown in green (FITC) and extracellular S. aureus is co-localized with both red (Cy-5) and
green (FITC). (C) Z-stack sections were used to confirm that all live S. aureus was inside osteoblasts as determined by the X-Y planes. Live S. aureus
are green (Syto 9) and dead S. aureus are red (PI). Osteoblasts were infected with Syto 9-labeled S. aureus, then extracellular bacteria were killed
with gentamicin and washed. Osteoblasts were detached from the wells and stained with PI. Approximately 20 cells (randomly selected) were
examined. (D) Confirmation of intracellular S. aureus within osteoblasts using TEM.
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showing that S. aureus infection not only significantly in-
creased the H2O2 levels in macrophages at 1 h infection
but also significantly increased the O.2
− levels in macro-
phages at infection times of 0.5 and 1 h. In contrast, S.
aureus infection induced significantly higher levels of
H2O2 in osteoblasts at 0.5 and 1 h infection but did not
induce significant changes in O.2
− levels in osteoblasts. As a
result, a significantly higher number of intracellular CFUs
was found in macrophages immediately after infection
while significantly less intracellular S. aureus survived in
the days following infection. Survival of S. aureus within
host cells was also reported in tissues and other cell types.
For instance, Tuchscherr et al. reported that S. aureus
could persist within host cells and/or tissues for severalweeks [36], survive within human lung epithelial cells
for up to 2 weeks [37], persist in macrophage vacuoles
for 3–4 days before escaping into the cytoplasm and
causing macrophage lysis [6], and remain viable for up
to 5 days within HT-29 and Caco-2 enterocytes [38]. It
was proposed that, once inside osteoblasts, macrophages,
or other cells, S. aureus may undergo phenotypic switch-
ing to small colony variants (SCVs), which are associated
with increased anchoring of fibronectin-binding proteins
and clumping factors on the bacterial surface [36,39].
These proteins may function as substrates for bacterial en-
zymes that are needed to evade phagocytic oxidative kill-
ing [6,40] thereby contributing to the intracellular survival
of S. aureus. Moreover, S. aureus produces catalase, which




Figure 4 Cellular and molecular responses of osteoblasts and macrophages infected with S. aureus at an MOI of 500:1 for 2 h. (A) DCF
fluorescence intensity as an indicator of H2O2 production by non-infected controls and S. aureus-infected osteoblasts and macrophages. (B) DHE
fluorescence intensity as an indicator of O.2
− production by non-infected controls and S. aureus-infected osteoblasts and macrophages. (C) Osteoblast
ALP activity measured at post-infection days 1, 4, and 7. (D) Macrophage phagocytosis activity (ingestion). Light gray area: control macrophages
without incubation with S. aureus; dark gray area: non-infected macrophages; black area: infected macrophages. *p < 0.01, **p < 0.001, ***p < 0.0001, and
#p < 0.05 compared to control.
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lieved that the phenotypic switching of S. aureus may
make the bacteria more resistant to antibiotics [17,42].
Similarly, S. epidermidis was found to persist in macro-
phages and also in peri-implant tissues in mice despite
antibiotic treatments [43,44]. The survival of S. aureus
within cells like macrophages and osteoblasts and the pos-
sible phenotypic switching of S. aureus may explain why
antibiotics have so often failed to cure Staphylococcal in-
fections [2,17,36]. In addition, the presence of antibodies
(e.g. anti-tumor necrosis factor-related apoptosis-inducing
ligand or TRAIL antibody) may improve the viability of
infected host cells and provide better protection for the
intra-cellular bacteria [45]. Alexander et al. found that in
the presence of 1 μg/mL of anti-TRAIL antibody, the per-
centage of apoptotic cells decreased from the control (in
the absence of antibody) of 32% to 28% [45]. Future stud-
ies may focus on investigation of the possible changes that
occur to S. aureus after internalization into osteoblasts
and macrophages and the effect of a variety of opsonins
potentially present in vivo. This study was limited to
in vitro cell studies which may not reflect what is happen-
ing in patients with chronic infections. In vivo studies using
chronic infection animal models, which may allow moni-
toring of intracellular presence of S. aureus with time, are
needed in the future.S. aureus infection also resulted in significantly in-
creased levels of H2O2 in infected osteoblasts at infection
times of 0.5 and 1 h and in infected macrophages at infec-
tion time of 1 h. The O.2
− levels in infected macrophages
significantly increased at infection times of 0.5 and 1 h.
The increase in reactive oxygen species indicates that S.
aureus internalization induced significant stress in osteo-
blasts and macrophages which would produce such che-
micals to eliminate the invading pathogens. S. aureus
infection also led to much higher phagocytosis activity of
macrophages and significantly lower ALP activity of osteo-
blasts at day 7 after infection. This effect could be associ-




is noteworthy that, besides the significant changes in re-
active oxygen species, S. aureus internalization in osteo-
blasts also led to significantly higher production of IL-6
and IL-12 [21,46], macrophage chemoattractant protein 1,
IL-8, IP-10, RANTES [21,46], and RANK-L and prosta-
glandin E2 (two important molecules that can promote os-
teoclastogenesis and bone resorption) [47].
Conclusions
We compared S. aureus internalization in a phagocytic cell
(i.e. macrophage) to a non-phagocytic cell (i.e. osteoblast)
and investigated the cells’ responses upon infection. We
found that S. aureus could internalize within macrophages
Hamza and Li BMC Microbiology 2014, 14:207 Page 7 of 11
http://www.biomedcentral.com/1471-2180/14/207and osteoblasts and, upon infection, a significantly higher
number of live intracellular S. aureus was observed in
macrophages compared to osteoblasts. The viability of
macrophages and osteoblasts both decreased with increas-
ing infection time and macrophages had significantly
lower viability during 2 h infection and significantly higher
viability during 8 h infection compared to osteoblasts.
Moreover, intracellular S. aureus was found to survive
within macrophages and osteoblasts for approximately
5 and 7 days, respectively. The percentage of S. aureus
survival within macrophages and osteoblasts decreased
with increasing post-infection time, and the percentage
of S. aureus survival within macrophages was significantly
lower compared to that within osteoblasts. Moreover, com-
pared to non-infected controls, S. aureus infection resulted
in (i) significantly increased hydrogen peroxide production
in macrophages and osteoblasts, (ii) significantly increased
superoxide anion production in macrophages but not in
osteoblasts, (iii) significantly lower alkaline phosphatase
activity in infected osteoblasts, and (iv) higher phagocyt-
osis activity in infected macrophages.
Methods
Reagents
Tryptic soy agar (TSA, w/5% sheep blood) plates, tryptic
soy broth (TSB), phosphate buffered saline (PBS), fetal
bovine serum (FBS), 0.25% trypsin/2.21 mM ethylenedi-
aminetetraacetic acid (EDTA) solution, 45% glucose so-
lution, 7.5% sodium bicarbonate, sodium pyruvate, and
HEPES buffer were all obtained from Fisher Scientific
(Pittsburgh, PA). Dulbecco’s Modified Eagle Media: Nu-
trient Mixture F-12 (DMEM/F12) and RPMI-1640 media
were purchased from LONZA (Walkersville, MD). DiI
fluorescent dye, Syto-9, propidium iodide (PI), and 100 U/mL
penicillin/100 mg/mL streptomycin solution were from
Invitrogen (Carlsbad, CA). Gentamicin, Triton X-100, cy-
tochalasin D, dimethyl sulfoxide (DMSO), bovine serum
albumin (BSA), lysostaphin, fluorescein isothiocyanate
(FITC), paraformaldehyde, and glutaraldehyde were ob-
tained from Sigma (St. Louis, MO). Primary antibody
Ab20920 and goat polyclonal to rabbit IgG second-
ary antibody-Cy5 ab6564 were obtained from Abcam
(Cambridge, MA). Dichlorofluorescin diacetate (H2DCF-DA)
and dihydroethidum (DHE) were from Life Technologies
(Grand Island, NY).
Bacteria
S. aureus (ATCC 25923) was obtained from the American
Type Culture Collection (ATCC, Manassas, VA). Bacteria
were prepared as we previously reported [48-52]. Briefly, a
fresh inoculum was prepared by suspending 5 colonies of
S. aureus, grown on a blood agar plate, in 5 mL TSB and
incubating at 37°C for 18 h. After incubation, the S. aureus
inoculum was centrifuged at 3750 rpm for 15 min at 4°C,washed once with 10 mL PBS, and the bacteria pellet was
diluted to (6–8) × 108 CFU/mL with sterile PBS. Next, the
bacteria were centrifuged again and the bacteria pellet was
then re-suspended in either DMEM/F12 for the infection
of osteoblasts or in RPMI-1640 medium for the infection
of macrophages; both cell culture media were free from
streptomycin/penicillin and FBS.
Infection of osteoblasts with S. aureus
Rat osteoblasts (UMR-106) were obtained from ATCC
and grown in full-supplemented DMEM/F12 medium
containing 10% FBS and 1% penicillin/streptomycin so-
lution. As previously reported [53,54], 3 × 105 cells/mL
were seeded in 12-well plates (Fisher Scientific) and cul-
tured in full-supplemented DMEM/F12 medium for at
least 24 h at 37°C in a 5% CO2 incubator until they
reached ~ 80% confluence. Osteoblasts were infected
and the effects of MOI and infection time on osteoblast
infection were investigated: (1) To examine the effect of
MOI on osteoblast infection, the osteoblast monolayer
was washed 3 times with PBS and then fresh DMEM/
F12 medium was added (free from streptomycin/peni-
cillin and FBS). Immediately, S. aureus was added at
MOIs of 100:1, 500:1, and 1000:1 and incubated for 2 h.
(2) To examine the effect of infection time on osteoblast
infection, the osteoblast monolayer was washed 3 times
with PBS and then fresh DMEM/F12 medium (free from
streptomycin/penicillin and FBS) was added. S. aureus
was added at an MOI of 500:1 and incubated for differ-
ent times, i.e. infection times, of 0.5, 2, 4, 6, and 8 h.
After each treatment, the osteoblast monolayer was
washed 3 times with PBS and treated with 100 μg/mL
gentamicin (an antibiotic known not to penetrate mam-
malian cell membranes within a few hours [55,56]) for
2 h at 37°C in a 5% CO2 incubator. Osteoblasts were
then washed 3 times with PBS and immediately lysed
with 0.1% Triton X-100 in PBS for 10 min at 37°C; the
cell lysates were diluted in PBS and plated on blood agar
plates overnight. The washing PBS was collected and
plated on blood agar plates overnight as well. To deter-
mine viability, osteoblasts were detached by incubating
them at 37°C for 3 min in a 0.25% trypsin/2.21 mM
EDTA solution; trypsinization was stopped by adding
DMEM/F12 medium supplemented with 10% FBS. Viable
osteoblasts were counted using a hemocytometer (Bright-
Line Hausser Scientific, Horsham, PA) [57] following the
trypan-blue exclusion assay which depends on cellular
membrane integrity; dead cells allow the stain to pene-
trate while live cells do not.
Infection of macrophages with S. aureus
A rat alveolar macrophage cell-line (NR 8383) was obtained
from ATCC and grown in full-supplemented RPMI-1640
medium containing 10% FBS, 1% streptomycin/penicillin,
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sodium pyruvate. The infection of macrophages with S.
aureus was studied at different MOIs and infection
times. The protocols for infecting macrophages were
similar to those of infecting osteoblasts as described
previously. In brief, to achieve adherence, 3 × 105 cells/mL
were seeded in 12-well plates and cultured in full-
supplemented RPMI-1640 medium for at least 24 h at
37°C in a 5% CO2 incubator. Cultured macrophages
were washed 3 times with PBS and then infected with
S. aureus at different MOIs (100:1, 500:1, and 1000:1)
or infection times (0.5-8 h). Infected macrophages
were washed, treated with gentamicin, washed again
(the washing media were collected and plated on blood
agar plates overnight), and then lysed to determine the
number of live intracellular S. aureus. To determine the via-
bility of macrophages, adherent macrophages were scraped
using a cell scraper (Fisher Scientific) and combined with
floating macrophages from the same sample for trypan-
blue exclusion assay and hemocytometry.
The viability of osteoblasts and macrophages after infec-
tion with S. aureus was calculated relevant to their control
(non-infected) cells according to the following equation:
Viability %ð Þ ¼
Number of live cell in infected sample
Number of live and dead cells in infected sample
Number of live cells in control sample
Number of live and dead cells in control sample
 100%
Note that the total cell numbers in the infected and
control samples were the same at the beginning of the
infection (i.e. infection time = 0 h) but were different at
later infection time periods (i.e. 0.5-8 h).
Inhibition of S. aureus internalization in osteoblasts
Cytochalasin D was reconstituted in 1% DMSO. 3 × 105
cells/mL were seeded in 12-well plates and cultured in
full-supplemented DMEM/F12 medium to reach ~ 80%
confluence. The osteoblast monolayer was washed 3
times with PBS and then fresh DMEM/F12 medium
was added (free from streptomycin/penicillin and FBS)
together with cytochalasin D (0.5, 1, 5, 10, and 20 μg/mL).
After culturing for 30 min, S. aureus was added at an
MOI of 500:1 and further incubated for 2 h. Following
treatment with gentamicin, infected osteoblasts were lysed
and plated to determine the number of live intracellular
bacteria.
Survival of S. aureus within osteoblasts or macrophages
Osteoblasts or macrophages were infected with S. aureus
at an MOI of 500:1 for 2 h, treated with gentamicin,
washed, and cultured for up to a week in DMEM/F12
(for osteoblasts) or RPMI-1640 (for macrophages) sup-
plemented with 5% FBS and 5 μg/mL lysostaphin; lysos-
taphin does not penetrate mammalian cell membranesfor long time periods, e.g. weeks [58-60]. The cell culture
medium was changed every 3 days. At post-infection days
0, 1, 3, 5, 6, 7, and/or 8 and 9, independent samples of in-
fected cells were washed with PBS, lysed with 0.1% Triton
X-100, and plated on blood agar plates to determine the
number of live intracellular S. aureus. The percentage of
live intracellular CFUs [53] at different times following in-
fection was calculated based on the live intracellular CFUs
immediately after infection (i.e. post-infection day 0).
Confocal microscopy
A dual staining approach [61,62] was adopted to visualize
intracellular S. aureus. Osteoblasts or macrophages were
cultured on rounded cover-slips for at least 24 h in full-
supplemented DMEM/F12 or RPMI-1640, respectively.
Fresh S. aureus was cultured for 18 h at 37°C in a 5% CO2
incubator. After washing the bacteria once with PBS, the
pellet was stained with 100 μg/mL FITC in PBS for
30 min at room temperature prior to infection. Excess
FITC was removed by washing with PBS and centrifuging
at 3750 rpm for 15 min at 4°C. After infecting with the
stained S. aureus for 2 h at an MOI of 500:1, osteoblasts
were trypsinized using a 0.25% trypsin/2.21 mM EDTA
solution for 30 seconds at room temperature to remove
adherent extracellular S. aureus; no trypsinization was
used in the macrophage samples. Osteoblasts or macro-
phages were then fixed with 4% paraformaldehyde in
distilled water for 30 min at room temperature. Fixed
cells were washed 3 times with PBS and blocked with
5% BSA for 1 h at room temperature. To further label
the extracellular S. aureus, the fixed cells were incubated
overnight at 4°C with a primary antibody Ab20920S in 5%
BSA, washed 3 times with PBS (to remove excess free pri-
mary antibody), and then incubated in the dark with a sec-
ondary antibody-conjugated Cy5 fluorescent dye in 2.5%
BSA for 45 min at room temperature. After washing the
excess secondary antibody with PBS, the cover-slips were
flipped onto microscopic glass slides and used for image
observation; macrophage samples were mounted in the
presence of 4′,6-diamidino-2-phenylindole (DAPI) fluor-
escent dye to visualize the nuclei of macrophages. Slides
were visualized using a 159 Plan-Apochromat 63x/1.40 oil
objective on an LSM 510 confocal microscope (Zeiss,
Jena, Germany).
To confirm the presence of live intracellular S. aureus
and the efficacy of gentamicin at killing extracellular S.
aureus, osteoblasts were seeded on a rounded cover-slip
overnight. The monolayer was then stained with DiI fluor-
escent dye for 20 min at 37°C in the dark. The monolayer
was washed once with PBS and infected with Syto-9 la-
beled S. aureus as aforementioned. After gentamicin treat-
ment, infected osteoblasts were washed 3 times with
HEPES buffer and PI stain was added for 15 min at room
temperature in the dark. Immediately after washing off
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510 confocal microscope and images of Z-stack sections
were taken to confirm the live intracellular S. aureus.
Z-stack sections were generated and the X-Y planes showed
that all live (green) S. aureus was inside the osteoblasts.
Transmission electron microscopy (TEM)
Osteoblasts were infected with S. aureus at an MOI of
500:1 for 2 h, washed once with PBS, and detached using
trypsin-EDTA. Osteoblasts were then collected by cen-
trifugation at 1200 rpm at 4°C for 7 min, and the pellet
was washed twice with PBS. Slides were then prepared
as previously reported [63]. In brief, osteoblasts were
fixed with 2% paraformaldehyde and 4% glutaraldehyde
mixed with 0.075 M PBS for 30 min at room temperature.
The fixed cell mass was collected in 1.5 mL Eppendorf
tubes. The cell pellet was washed 3 times with PBS, post-
fixed in 1% osmium tetroxide for 2 h at room temperature,
washed 3 times with PBS, treated with aqueous 1% tannic
acid for 1 h at room temperature, and then dehydrated
in a gradient ethanol series. The cells were embedded in
pure LR white resin solution and polymerized at 60°C
for 24–48 h. Thin (0.1 μm) sections were cut and placed
on nickel grids, stained with 2% uranyl acetate and lead
citrate, and viewed using TEM (JEOL, Peabody, MA).
Reactive oxygen species production
Osteoblasts and macrophages were infected with S. aureus
at an MOI of 500:1. At pre-determined time points (0.5, 1,
and 2 h), samples of infected osteoblasts or macrophages
were taken, washed once with PBS, and then incubated
with H2DCF-DA or DHE at 37°C for 1 h in the dark; sep-
arate samples were used for the staining of H2DCF-DA
and DHE. Non-infected osteoblasts and macrophages
were used as controls and were treated the same as the in-
fected cells except no S. aureus was added. Viable cells of
infected and control samples at the pre-determined time
points were obtained using hemocytometry and were used
to analyze the final fluorescent data. The fluorescence in-
tensity was measured using a fluorescent microplate reader
(BioTek Instrument, Inc., Winooski, VT) at 492 nm/
520 nm for 2′,7′-dichlorofluorescein (DCF), converted
intracellularly from H2DCF-DA, and 492 nm/620 nm
for DHE. H2DCF-DA and DHE are commonly used to
stain intracellular H2O2 and O
.
2
−, respectively [64]. The
acetate groups of H2DCF-DA are cleaved by intracellu-
lar esterases and oxidation and convert to highly fluor-
escent DCF.
Osteoblast alkaline phosphatase (ALP) activity
Osteoblasts were cultured in 12-well plates at a density
of 5 × 104 cells/mL, infected at an MOI of 500:1 for 2 h
following the aforementioned infection protocol. Non-
infected (control) and infected osteoblasts were culturedin DMEM/F12 supplemented with 5% FBS and 5 μg/mL
lysostaphin solution for a week; medium was changed
every 3 days. On post-infection days 1, 4, and 7, osteoblast
monolayers were washed with PBS once and the ALP ac-
tivity was determined using an ALP assay kit (Abcam) and
expressed as Unit/mL.
Macrophage phagocytosis assay
Macrophage phagocytosis (ingestion) activity was tested
by measuring the uptake of FITC-labeled S. aureus by
non-infected (control) macrophages and macrophages
infected with S. aureus (unlabeled) at an MOI of 500:1
for 2 h. After incubating 5 × 105 cells/mL non-infected
(control) and infected macrophages separately with FITC-
labeled S. aureus at 10:1 MOI for 2 h, macrophages (in-
fected and non-infected) were treated with 100 μg/mL
gentamicin for 2 h at 37°C in a 5% CO2 incubator.
Macrophages were then scraped and collected for flow
cytometry analysis using BD-FACS Calibur (BD, Frank-
lin Lakes, NJ); 10,000 events were collected. Data were
acquired in logarithmic mode for the forward scatter
(FSC), side scatter (SSC), and green fluorescence channel
FL-1H (i.e. FITC). Control macrophages were subjected to
the same experimental protocols as the infected cells but
without infection with S. aureus. The percentage of mac-
rophages with FITC fluorescent intensity corresponds to
the ingestion activity of macrophages.
Statistical analysis
Statistical analyses were performed using JMP Statistical
Visualization Software (SAS Institute, Cary, NC). Experi-
ments were repeated at least twice on separate days to ver-
ify reproducibility. All data were expressed as mean ± SD
and analyzed using one-way analysis of variance (ANOVA).
Statistical significance was set at p < 0.05, 0.01, 0.001,
or 0.0001.
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